The
global 3D Printed Drugs Market size is expected to reach
USD 269.74 million by 2030, according to a new report by Grand View Research,
Inc. The market is expected to expand at a CAGR of 15.32% from 2022 to 2030.
The rising prevalence of chronic diseases, combined with the rising
population of patients with dysphagia around the globe is pushing the
demand for immediate soluble medications, which is likely to drive the market.
For instance, according to a study published in April 2022, the prevalence of
oropharyngeal dysphagia is high in conditions such as stroke and aging and is
reported to be 26.19% in the elderly.
An
increase in the aging population has led to the growing demand for the
development of easy-to-swallow pills for the elderly. The 3D printed highly
soluble and easy-to-swallow drugs can help the elderly who have difficulty
swallowing. Moreover, according to the United Nations, the number of people
aged 65 and more in 2050 is projected to be 1.5 billion. Thus, the growing
elderly population across the world would propel the demand for easy-to-swallow
drugs resulting in market growth.
Other
factors such as quickly expanding demand for pharmaceuticals, technical
improvements in healthcare, as well as the government's focus and expenditures
in the 3D printing industry, are also contributing to the market's
growth. For instance, in March 2022, Evonik Venture Capital invested in
Nevada-based Laxxon Medical for the manufacturing of 3D-printed tablets. The
latter company has developed a 3D screen-printing technology for the production
of structured tablets with the controlled release of API over time. Such
investments are likely to supplement the market growth in the coming years.
The
COVID-19 pandemic is anticipated to positively impact market growth. Several
printers have been launched by the operating companies in the advanced
manufacturing industry to help increase the manufacturing of medications and
other necessary products. As a result, the usage of these technologies is
projected to increase during the COVID-19 pandemic.
The
growing demand for personalized medicine is expected to majorly drive market
growth in the coming years. As 3D printing of pharmaceutical drugs can produce
personalized medicine in small batches with carefully tailored shapes, dosages,
and sizes, the market is anticipated to grow at an exponential rate in the near
future. In addition, the use of 3D printing technology can significantly reduce
manufacturing costs thus, further increasing investments in this space.
On
the other hand, adverse effects from these drugs, the use of 3D printing to
create illegal drugs, and a lack of government restrictions for 3D printed
products are limiting the market's growth. For instance, in March 2018, a
police case was filed in Amsterdam, for the illegal handling of these drugs.
However, increased awareness of the benefits of these medications, such as
their immediate solubility, faster manufacturing time, reduced waste, and easy
on-demand manufacturing is likely to create multiple prospects for market
growth.
Related Press
Release@ 3D Printed Drugs Market Report
3D Printed Drugs Market Report Highlights
- By
technology, the zip dose segment held the largest share of the 3D market.
This is attributed to the increase in the requirement for rapid soluble
drugs that disperse quickly in the mouth, which in turn is likely to
increase the adoption and anticipate market growth.
- The inkjet
printer segment is expected to grow lucratively during the forecast
period. Due to the 3D medications can be personalized to each
patient's needs, assisting them far more than batch-produced medicines,
their demand is expected to skyrocket in the coming years.
- By
application, the neurology segment held a larger share of the global
market. This is attributed to an increase in the proportion of older
people, which is at an increased risk of developing neurological disorders
and hence, propelling the market growth.
- By end-use,
the hospitals & clinics segment held a larger share in 2021, owing to
the growing demand for personalized medicines and the cost-effective use
of bio-drugs employing this technology.
- North
America dominated the global market in 2021 due to the availability of
technologically advanced healthcare research framework, the presence of
high R&D investment, and the development of 3D printed drugs in the
region.
- The Asia
Pacific is expected to grow considerably in the future owing to the rising
prevalence of chronic diseases and the presence of key players.
- A few of the
key market players include 3D Printer Drug Machine, Aprecia
Pharmaceuticals, BV LLC, Hewlett Packard Caribe, and others.
Related Category Reports@
3D Printed Drugs Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2022 |
USD 86.24 million |
|
Revenue forecast in 2030 |
USD 269.74 million |
|
Growth rate |
CAGR of 15.32% from 2022 to 2030 |
|
Base year for estimation |
2021 |
|
Historical data |
2018 - 2020 |
|
Forecast period |
2021 - 2030 |
3D Printed Drugs Market Segmentation
Grand
View Research has segmented the global 3D printed drugs market based on
technology, application, end-user, and region:
Technology Scope Outlook (Revenue, USD Million, 2018 -
2030)
- Inkjet
Printing
- Fused
Deposition Modeling
- Stereolithography
- ZipDose
Technology
Application Scope Outlook (Revenue, USD Million, 2018 -
2030)
- Orthopedic
- Neurology
- Dental
- Others
End-use Scope Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
& Clinics
- Research
Laboratories
- Others
Regional Scope Outlook (Revenue, USD Million, 2018 -
2030)
- North
America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- South Korea
- Latin
America
- Brazil
- Mexico
- Middle East
& Africa
- South
Africa
- Saudi
Arabia
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment